Colonial Trust Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-13
Closed -$1.8K 837
2024
Q1
$1.8K Sell
13
-7
-35% -$880 ﹤0.01% 808
2023
Q4
$2.48K Sell
20
-9
-31% -$919 ﹤0.01% 686
2023
Q3
$2.71K Hold
29
﹤0.01% 681
2023
Q2
$3.73K Hold
29
﹤0.01% 670
2023
Q1
$3.37K Buy
29
+3
+12% +$336 ﹤0.01% 667
2022
Q4
$2.94K Buy
+26
New +$2.85K ﹤0.01% 679

Other funds holding DXCM

Colonial Trust Advisors's DXCM Position: Q2 2024 in Review

Colonial Trust Advisors sold out of DexCom (DXCM) in Q2 2024, closing a stake of 13 shares — an estimated $1.8K sold.

Colonial Trust Advisors first reported a position in DXCM in Q4 2022 and held it in 6 quarters. The position peaked at $3.73K in Q2 2023. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Colonial Trust Advisors reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Colonial Trust Advisors sold 13 DexCom shares in Q2 2024, an estimated $1.8K.
  • Colonial Trust Advisors first reported a position in DexCom in Q4 2022 and held it in 6 quarters.
  • Colonial Trust Advisors's DexCom position peaked at $3.73K in Q2 2023.
  • 999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Colonial Trust Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.